Epigenetics in Lewy Body Diseases: Impact on Gene Expression, Utility as a Biomarker, and Possibilities for Therapy

Lewy body disorders (LBD) include Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). They are synucleinopathies with a heterogeneous clinical manifestation. As a cause of neuropathological overlap with other neurodegenerative diseases, the establishment of a correct clinical diagnosis is...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbizu, Aintzane, Beyer, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369933/
https://www.ncbi.nlm.nih.gov/pubmed/32630630
http://dx.doi.org/10.3390/ijms21134718

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369933/
https://www.ncbi.nlm.nih.gov/pubmed/32630630
http://dx.doi.org/10.3390/ijms21134718

Ejemplares similares